COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.
Barron’s Top Weekend Stock Picks: General Motors, Netflix, Ally Financial And Famous Tesla Bear And Bull Debate
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Metaverse Will Be As ‘Important As The Smartphone’: Meta Platforms Chief Product Officer
During a panel at the World Economic Forum in Davos, Switzerland, Chris Cox, chief product officer at Meta Platforms Inc (NASDAQ: META), said the metaverse will one day becom
AI Battle: Gates, Brin, Page, The OGs Of Tech Leave ‘Retirement’ For Heavyweight Fight
A handful of tech visionaries from the late 1990s to early 2000s are re-engaging or revealing a continued involvement with their former companies in the wake of the release of OpenAI's ChatGPT.
Google Layoffs 12K Employees, Netflix’s Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly’s Alzheimer’s Candidate: Top Stories Friday, Jan. 20
Here's a round-up of stories from around the globe and from various media outlets.
Benzinga
EXCLUSIVE: Benzinga Poll Reveals Top Picks For A $25,000 Long-Term Investment In 2023
After a sour year in the stock market that saw the broad market S&P 500 (ARCA: SPY) fall nearly 20%, and other pandemic-darlings like Apple Inc (NASDAQ: AAPL), and Amazon.com, Inc (NASDAQ: AMZN) fal
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).
Rite Aid Starts Selling Abortion Medication From Few Pharmacies: Report
Rite Aid Corp (NYSE: RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery.
FDA Rejects Eli Lilly’s Donanemab For Alzheimer’s Disease, Needs More Data
The FDA issued a complete response letter for the accelerated approval submission of Eli Lilly And Co’s (NYSE:LLY) donanemab for early symptomatic…
What To Expect When General Dynamics Reports Fourth Quarter Results Next Week
Credit Suisse expected General Dynamics Corp (NYSE: GD) to report fourth-quarter FY22 slightly ahead, with upside potential driven by G650 delivery strength and repurchases, when the aerospace and defense giant reports its earnings next week on Jan. 25.